However, mice that received the combined treatment of GAU1 ASO and H101 demonstrated a notably greater reduction in tumor growth (n = 5, *P < 0.05) than those subjected to treatment administered individually, and the overall inhibition rate of tumor growth was approximately 88% (Fig. 4C). The gene discussed is GAU1; the disease is neoplasm.